TANG KEVIN bought AUPH

June 1, 2026 · Form 4 insider transaction

TANG KEVIN bought 343,521 shares of Aurinia Pharmaceuticals Inc. at $15.28 per share, a transaction worth $5.25M. The trade was recorded as open-market purchase and disclosed on an SEC Form 4, filed 1 day after the transaction.

Direction
Acquired (buy-side)
Shares
343,521
Price
$15.28
Total value
$5.25M
InsiderTANG KEVIN
RoleOfficer, Director, 10% owner
SecurityCommon Shares
Transaction codeP: Open-market purchase
Transaction dateJune 1, 2026
Filing dateJune 2, 2026
Shares owned after12,838,002
OwnershipIndirect
10b5-1 planNo
AmendedNo

Footnotes

These shares were purchased in multiple transactions ranging from $14.97 to $15.50.; Tang Capital Partners, LP ("TCP") beneficially owns 7,205,442 shares, Tang Capital Partners International, LP ("TCPI") beneficially owns 5,239,039 shares, Tang Capital Partners III, Inc. ("TCP III") beneficially owns 324,814 shares, and Tang Capital Partners IV, Inc. ("TCP IV") beneficially owns 274,811 shares. Kevin Tang is the sole manager of Tang Capital Management, LLC, which is the general partner of TCP and TCPI. Kevin Tang is the sole director and Chief Executive Officer of TCP III and TCP IV, which are indirectly wholly owned by TCP. Mr. Tang has a pecuniary interest in the shares beneficially held by TCP, TCPI, TCP III and TCP IV (collectively, the "Funds").

View the original Form 4 on SEC EDGAR